| Kyle Arnet, DO | |
|
320 Alpenglow Ln, Livingston, MT 59047 | |
| (406) 222-3541 | |
| (406) 823-6287 |
| Full Name | Kyle Arnet |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 320 Alpenglow Ln, Livingston, Montana |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1689915241 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 5101020588 (Michigan) | Primary |
| Entity Name | Livingston Healthcare |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245222306 PECOS PAC ID: 5991613598 Enrollment ID: O20031122000111 |
News Archive
A new study released this Wednesday revealed that breast cancer that is highly aggressive but caught early could be best treated with a combination of Herceptin and chemotherapy.
Female kidney donors who are overweight may be at a greater risk for preeclampsia during pregnancy, according to a new study.
Contrary to previous reports, new research shows that cancer patients can not intentionally postpone death to survive for significant personal events such as Christmas, Thanksgiving or a birthday, according to a study in the December 22/29 issue of JAMA.
Building on an earlier study that used Oncomine to identify ETS-fusion proteins in prostate cancer (Science, Oct 28 2005), Tomlins et al. report the identification of four additional classes of ETS rearrangements in prostate cancer, each of which activates ETV1 by a different genetic mechanism (Nature, Aug 2 2007).
According to research presented this week at the American College of Rheumatology Annual Scientific Meeting in Chicago, people taking anti-tumor necrosis factor therapies to treat rheumatoid arthritis have a higher risk of developing malignant melanoma.
› Verified 6 days ago
| Entity Name | Livingston Healthcare |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1245222306 PECOS PAC ID: 5991613598 Enrollment ID: O20061104000158 |
News Archive
A new study released this Wednesday revealed that breast cancer that is highly aggressive but caught early could be best treated with a combination of Herceptin and chemotherapy.
Female kidney donors who are overweight may be at a greater risk for preeclampsia during pregnancy, according to a new study.
Contrary to previous reports, new research shows that cancer patients can not intentionally postpone death to survive for significant personal events such as Christmas, Thanksgiving or a birthday, according to a study in the December 22/29 issue of JAMA.
Building on an earlier study that used Oncomine to identify ETS-fusion proteins in prostate cancer (Science, Oct 28 2005), Tomlins et al. report the identification of four additional classes of ETS rearrangements in prostate cancer, each of which activates ETV1 by a different genetic mechanism (Nature, Aug 2 2007).
According to research presented this week at the American College of Rheumatology Annual Scientific Meeting in Chicago, people taking anti-tumor necrosis factor therapies to treat rheumatoid arthritis have a higher risk of developing malignant melanoma.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kyle Arnet, DO 320 Alpenglow Ln, Livingston, MT 59047-8506 Ph: (406) 222-3541 | Kyle Arnet, DO 320 Alpenglow Ln, Livingston, MT 59047 Ph: (406) 222-3541 |
News Archive
A new study released this Wednesday revealed that breast cancer that is highly aggressive but caught early could be best treated with a combination of Herceptin and chemotherapy.
Female kidney donors who are overweight may be at a greater risk for preeclampsia during pregnancy, according to a new study.
Contrary to previous reports, new research shows that cancer patients can not intentionally postpone death to survive for significant personal events such as Christmas, Thanksgiving or a birthday, according to a study in the December 22/29 issue of JAMA.
Building on an earlier study that used Oncomine to identify ETS-fusion proteins in prostate cancer (Science, Oct 28 2005), Tomlins et al. report the identification of four additional classes of ETS rearrangements in prostate cancer, each of which activates ETV1 by a different genetic mechanism (Nature, Aug 2 2007).
According to research presented this week at the American College of Rheumatology Annual Scientific Meeting in Chicago, people taking anti-tumor necrosis factor therapies to treat rheumatoid arthritis have a higher risk of developing malignant melanoma.
› Verified 6 days ago
Krista Arnet, DO Emergency Medicine Medicare: Medicare Enrolled Practice Location: 320 Alpenglow Ln, Livingston, MT 59047 Phone: 406-222-3541 | |
Dr. Warren Lee Liebers, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 320 Alpenglow Ln, Livingston, MT 59047 Phone: 406-222-3541 | |
Allan R Supak, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 320 Alpenglow Lane, Livingston, MT 59047 Phone: 406-823-6414 Fax: 406-823-6287 |